ロード中...
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis
BACKGROUND AND PURPOSE: Highly vascularized ovarian carcinoma secretes the putative endocannabinoid and GPR55 agonist, L-α-lysophosphatidylinositol (LPI), into the circulation. We aimed to assess the involvement of this agonist and its receptor in ovarian cancer angiogenesis. EXPERIMENTAL APPROACH:...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543616/ https://ncbi.nlm.nih.gov/pubmed/25989290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13196 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|